Chemoinformaics analysis of 7-METHOXYARISTOLOCHIC-ACID-A
| Molecular Weight | 371.301 | nRot | 4 |
| Heavy Atom Molecular Weight | 358.197 | nRig | 22 |
| Exact Molecular Weight | 371.064 | nRing | 4 |
| Solubility: LogS | -4.188 | nHRing | 1 |
| Solubility: LogP | 3.503 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 3 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 16 |
| nHA | 7 | APOL | 46.2443 |
| nHD | 1 | BPOL | 22.0197 |
| QED | 0.421 |
| Synth | 2.665 |
| Natural Product Likeliness | 0.701 |
| NR-PPAR-gamma | 0.431 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.861 |
| MDCK | 0.0000367 |
| BBB | 0.027 |
| PPB | 0.921319 |
| VDSS | 0.635 |
| FU | 0.0824007 |
| CYP1A2-inh | 0.621 |
| CYP1A2-sub | 0.764 |
| CYP2c19-inh | 0.127 |
| CYP2c19-sub | 0.11 |
| CYP2c9-inh | 0.609 |
| CYP2c9-sub | 0.398 |
| CYP2d6-inh | 0.68 |
| CYP2d6-sub | 0.145 |
| CYP3a4-inh | 0.266 |
| CYP3a4-sub | 0.048 |
| CL | 4.783 |
| T12 | 0.421 |
| hERG | 0.097 |
| Ames | 0.922 |
| ROA | 0.155 |
| SkinSen | 0.703 |
| Carcinogencity | 0.928 |
| EI | 0.312 |
| Respiratory | 0.935 |
| NR-Aromatase | 0.072 |
| Antiviral | Yes |
| Prediction | 0.668888 |